Delivery Order SPE2DB20D1100-SPE2DB25FD6J3
- Not listed
- The Defense Logistics Agency awarded a $3,676.12 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Ingrezza 40 mg capsules (30-count units). The contract, which is not set-aside, carries a firm fixed price structure with an ultimate completion date of August 21, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. This award represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ingrezza 40 mg capsules (30-count units) under a firm fixed-price contract with a ceiling value of $3,676.12. The delivery order, issued on July 18, 2025, with an ultimate completion date of August 8, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ingrezza 80 mg capsules (30-count units) under a firm fixed price contract valued at $4,027.70, with an ultimate completion date of August 15, 2025. This non-competitive delivery order was issued on July 25, 2025, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The award represents a child order under the company's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Ingrezza 80 mg capsules (30-count units) with a ceiling value of $4,027.70. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement valued through December 2026. The award carries no set-aside designation, indicating it was...
- The Defense Logistics Agency awarded a delivery order valued at $7,352.24 to AmerisourceBergen Drug Corp for the supply of Ingrezza 40 mg capsules (30-count units). This firm fixed price, non-competitive delivery order was awarded on August 4, 2025, with an ultimate completion date of August 25, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Ingrezza is a specialized neurological medication used in the treatment of tardive dyskinesia,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Ingrezza 80 mg capsules (30-count units) under a firm fixed-price contract with a ceiling value of $4,027.70. This non-set-aside delivery order is scheduled for completion by August 18, 2025, with performance conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order issued against the vendor's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $4,027.70 to supply Ingrezza 80 mg capsules (30-count packaging) with a firm fixed price structure. The award, issued on August 5, 2025, is scheduled for completion by August 26, 2025, and represents a non-set-aside, competitively awarded contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order valued at $4,027.70 to AmerisourceBergen Drug Corp for the supply of Ingrezza 80 mg capsules (30-count units) under a firm fixed-price contract. The award was made on July 30, 2025, with an ultimate completion date of August 20, 2025, with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the delivery from its corporate office location. This delivery order represents a specific...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,676.12 to AmerisourceBergen Drug Corp for the supply of Ingrezza 40 mg capsules (30-count units). This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 25, 2025, with performance conducted at the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was applied to this contract action. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ingrezza 60 mg capsules (30-count units) with a ceiling value of $4,049.61. This firm fixed-price, competitively awarded delivery order is scheduled for completion by August 12, 2025, with performance taking place at the contractor's Conshohocken, Pennsylvania location. The contract represents a non-set-aside procurement executed under DLA's broader pharmaceutical supply framework for...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD6J3Delivery Order
The Defense Logistics Agency awarded a $3,676.12 delivery order to AmerisourceBergen Drug Corp for the supply of Ingrezza 40 mg capsules (30-count) under a firm fixed price contract. The award was issued on July 24, 2025, with an ultimate completion date of August 14, 2025, and performance will be executed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a non-competitive, non-set-aside award and is characterized as a child contract, indicating it falls under a larger indefinite delivery vehicle. This award is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen Drug Corp provides a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. Ingrezza, a specialty neurological medication, exemplifies the specialized pharmaceutical products the contractor delivers through its extensive federal contract portfolio, which encompasses brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains serving the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 7/24/25 |